Characterization of brain-associated rabies neutralizing substance.
D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis*; D000956:Antigens, Viral / Q000032:analysis; D001921:Brain / Q000276:immunology; D002499:Centrifugation, Density Gradient; D002555:Cerebrospinal Fluid / Q000382:microbiology; D003168:Complement Fixation Tests; D004285:Dogs; D004591:Electrophoresis, Polyacrylamide Gel; D005455:Fluorescent Antibody Technique; D006168:Guinea Pigs; D006386:Hemagglutination Tests; D007106:Immune Sera; D007114:Immunization; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G / Q000032:analysis; D051379:Mice; D009500:Neutralization Tests; D010527:Perissodactyla / Q000276:immunology; D011818:Rabies / Q000276:immunology*; D011819:Rabies Vaccines; D011820:Rabies virus / Q000276:immunology* / Q000302:isolation & purification
D000914:Antibodies, Viral; D000956:Antigens, Viral; D007106:Immune Sera; D007074:Immunoglobulin G; D011819:Rabies Vaccines